Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
USANA Health Sciences Yönetim
Yönetim kriter kontrolleri 3/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Jim Brown
İcra Kurulu Başkanı
US$2.5m
Toplam tazminat
CEO maaş yüzdesi | 28.7% |
CEO görev süresi | 7.9yrs |
CEO sahipliği | n/a |
Yönetim ortalama görev süresi | 7.7yrs |
Yönetim Kurulu ortalama görev süresi | 6.6yrs |
Son yönetim güncellemeleri
Recent updates
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Sep 26Is There Now An Opportunity In USANA Health Sciences, Inc. (NYSE:USNA)?
Sep 08USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jul 26There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding
Jul 17USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively
May 29USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 03Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?
May 01USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares
Apr 04USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Feb 08Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?
Jan 06USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation
Oct 23Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?
Sep 09Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital
Jul 27USANA Earnings Preview: From China's Challenge To India's Promise
Jul 21USANA Health Sciences says Brown will transition to CEO in July 2023
Feb 13Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture
Feb 02USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates
Oct 25Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return
Oct 18Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?
Jul 22Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled
Jul 07Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?
Jun 14Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?
May 31USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside
Apr 28CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Jun 29 2024 | n/a | n/a | US$55m |
Mar 30 2024 | n/a | n/a | US$62m |
Dec 30 2023 | US$2m | US$710k | US$64m |
Sep 30 2023 | n/a | n/a | US$60m |
Jul 01 2023 | n/a | n/a | US$63m |
Apr 01 2023 | n/a | n/a | US$65m |
Dec 31 2022 | US$2m | US$624k | US$69m |
Oct 01 2022 | n/a | n/a | US$77m |
Jul 02 2022 | n/a | n/a | US$89m |
Apr 02 2022 | n/a | n/a | US$108m |
Jan 01 2022 | US$2m | US$600k | US$117m |
Oct 02 2021 | n/a | n/a | US$136m |
Jul 03 2021 | n/a | n/a | US$139m |
Apr 03 2021 | n/a | n/a | US$129m |
Jan 02 2021 | US$2m | US$599k | US$125m |
Sep 26 2020 | n/a | n/a | US$116m |
Jun 27 2020 | n/a | n/a | US$110m |
Mar 28 2020 | n/a | n/a | US$103m |
Dec 28 2019 | US$2m | US$559k | US$101m |
Sep 28 2019 | n/a | n/a | US$102m |
Jun 29 2019 | n/a | n/a | US$109m |
Mar 30 2019 | n/a | n/a | US$121m |
Dec 29 2018 | US$2m | US$534k | US$126m |
Sep 29 2018 | n/a | n/a | US$88m |
Jun 30 2018 | n/a | n/a | US$81m |
Mar 31 2018 | n/a | n/a | US$70m |
Dec 30 2017 | US$1m | US$523k | US$63m |
Tazminat ve Piyasa: Jim 'ın toplam tazminatı ($USD 2.47M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 3.23M ).
Tazminat ve Kazançlar: Jim şirketinin tazminatı %20'den fazla artarken, şirketin kazancı geçen yıl %20'den fazla düştü.
CEO
Jim Brown (55 yo)
7.9yrs
Görev süresi
US$2,472,017
Tazminat
Mr. Jim Brown has been the President of USANA Health Sciences Inc. since November 2016 and served as its Chief Operating Officer since November 2013 until October 2019. He serves as Chief Executive Officer...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Executive Chairman | 7.4yrs | US$3.91m | 0.064% $ 443.1k | |
CEO & President | 7.9yrs | US$2.47m | Veri yok | |
Chief Financial Officer | 7.4yrs | US$1.47m | 0% $ 0 | |
Chief Operating Officer | 5yrs | US$1.42m | Veri yok | |
Chief Legal Officer | 6.3yrs | US$1.29m | Veri yok | |
Chief Communications & Marketing Officer | 12.8yrs | US$1.15m | 0% $ 0 | |
Founder & Chairman Emeritus | 32.8yrs | Veri yok | 41.28% $ 286.2m | |
Executive Director of Product Development & Technology | 11.8yrs | Veri yok | Veri yok | |
Chief Scientific Officer | 8.2yrs | Veri yok | Veri yok | |
Chief Information Officer | no data | Veri yok | Veri yok | |
Executive Director of Investor Relations & Business Development | no data | Veri yok | Veri yok | |
Chief People Officer | 3.7yrs | US$637.78k | 0% $ 0 |
7.7yrs
Ortalama Görev Süresi
58yo
Ortalama Yaş
Deneyimli Yönetim: USNA 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.7 yıldır).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Executive Chairman | 7.4yrs | US$3.91m | 0.064% $ 443.1k | |
Founder & Chairman Emeritus | 4.4yrs | Veri yok | 41.28% $ 286.2m | |
Lead Independent Director | 16.1yrs | US$251.60k | 0% $ 0 | |
Independent Director | 5.8yrs | US$231.40k | 0.019% $ 132.3k | |
Independent Director | 5yrs | US$218.40k | 0.031% $ 215.6k | |
Member of Scientific Advisory Council | no data | Veri yok | Veri yok | |
Member of Scientific Advisory Council | no data | Veri yok | Veri yok | |
Chairperson of Scientific Advisory Council | 20.8yrs | Veri yok | Veri yok | |
Member of Scientific Advisory Council | no data | Veri yok | Veri yok | |
Member of Scientific Advisory Council | no data | Veri yok | Veri yok | |
Independent Director | 8.4yrs | US$233.60k | 0.020% $ 140.0k | |
Independent Director | 2.3yrs | US$218.40k | 0.019% $ 129.6k |
6.6yrs
Ortalama Görev Süresi
68yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: USNA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.6 yıldır).